GB0612326D0 - Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms - Google Patents

Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Info

Publication number: GB0612326D0
Authority: GB; United Kingdom
Prior art keywords: methods; dosage forms; sustained release; oral dosage; release oral
Prior art date: 2005-10-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0612326.9A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alza Corp

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-31

Filing date

2006-06-21

Publication date

2006-08-02

2006-06-21 Application filed by Alza Corp filed Critical Alza Corp

2006-08-02 Publication of GB0612326D0 publication Critical patent/GB0612326D0/en

2006-08-22 Priority to GB0616703A priority Critical patent/GB2431875A/en

2006-08-22 Priority to EP06254394A priority patent/EP1849460A3/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

GBGB0612326.9A 2005-10-31 2006-06-21 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms Ceased GB0612326D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB0616703A GB2431875A (en)	2005-10-31	2006-08-22	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
EP06254394A EP1849460A3 (en)	2005-10-31	2006-08-22	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US73199505P	2005-10-31	2005-10-31
US80201706P	2006-05-18	2006-05-18

Publications (1)

Publication Number	Publication Date
GB0612326D0 true GB0612326D0 (en)	2006-08-02

Family

ID=36758362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0612326.9A Ceased GB0612326D0 (en)	2005-10-31	2006-06-21	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms

Country Status (11)

Country	Link
BG (1)	BG1070U1 (en)
CA (6)	CA2554874A1 (en)
CZ (1)	CZ19137U1 (en)
DK (1)	DK200600189U3 (en)
FI (1)	FI7357U1 (en)
GB (1)	GB0612326D0 (en)
IE (1)	IES20060507A2 (en)
NL (1)	NL1032148C1 (en)
NO (1)	NO20063233L (en)
SE (1)	SE0601589L (en)
SK (1)	SK5202Y1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2187873T3 (en)	2007-08-13	2019-01-31	Abuse Deterrent Pharmaceutical Llc	Abuse resistant drugs, method of use and method of making
US20140275149A1 (en)	2013-03-15	2014-09-18	Inspirion Delivery Technologies, Llc	Abuse deterrent compositions and methods of use
US10729685B2 (en)	2014-09-15	2020-08-04	Ohemo Life Sciences Inc.	Orally administrable compositions and methods of deterring abuse by intranasal administration
US10172842B2 (en) *	2015-09-11	2019-01-08	PharmaDax Inc.	Sustained release oral dosage form containing dalfampridine
AU2018390826B2 (en)	2017-12-20	2024-09-12	Purdue Pharma L.P.	Abuse deterrent morphine sulfate dosage forms

2006
- 2006-06-21 GB GBGB0612326.9A patent/GB0612326D0/en not_active Ceased
- 2006-07-11 IE IE20060507A patent/IES20060507A2/en not_active IP Right Cessation
- 2006-07-11 NO NO20063233A patent/NO20063233L/en not_active Application Discontinuation
- 2006-07-11 NL NL1032148A patent/NL1032148C1/en not_active IP Right Cessation
- 2006-07-12 DK DK200600189U patent/DK200600189U3/en not_active IP Right Cessation
- 2006-07-12 FI FI20060296U patent/FI7357U1/en not_active IP Right Cessation
- 2006-07-12 CZ CZ200617928U patent/CZ19137U1/en not_active IP Right Cessation
- 2006-07-13 SK SK5057-2006U patent/SK5202Y1/en unknown
- 2006-07-20 SE SE0601589A patent/SE0601589L/en not_active Application Discontinuation
- 2006-07-31 CA CA002554874A patent/CA2554874A1/en not_active Abandoned
- 2006-07-31 CA CA002554698A patent/CA2554698A1/en not_active Abandoned
- 2006-07-31 CA CA002554701A patent/CA2554701A1/en not_active Abandoned
- 2006-07-31 CA CA002554684A patent/CA2554684A1/en not_active Abandoned
- 2006-07-31 CA CA002554693A patent/CA2554693A1/en not_active Abandoned
- 2006-07-31 CA CA002554697A patent/CA2554697A1/en not_active Abandoned
- 2006-12-21 BG BG1150U patent/BG1070U1/en unknown

Also Published As

Publication number	Publication date
CA2554697A1 (en)	2007-04-30
SK5202Y1 (en)	2009-06-05
FIU20060296U0 (en)	2006-07-12
CA2554684A1 (en)	2007-04-30
CA2554693A1 (en)	2007-04-30
SE0601589L (en)	2007-05-01
NO20063233L (en)	2007-05-02
IES20060507A2 (en)	2007-05-30
CA2554701A1 (en)	2007-04-30
CA2554698A1 (en)	2007-04-30
SK50572006U1 (en)	2009-01-07
FI7357U1 (en)	2007-01-16
NL1032148C1 (en)	2006-11-17
DK200600189U3 (en)	2007-02-23
CA2554874A1 (en)	2007-04-30
CZ19137U1 (en)	2008-12-08
BG1070U1 (en)	2008-06-30

Publication	Publication Date	Title
PL1951232T3 (en)	2013-09-30	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
IL268462A (en)	2019-09-26	Dosage forms of risedronate
IL182964A0 (en)	2007-08-19	Gabapentin prodrug sustained release oral dosage forms
SI2046298T1 (en)	2017-03-31	Pharmaceutical dosage form containing pharmaceutically acceptable solubilizing composition
ZA200810164B (en)	2009-11-25	Sustained release pharmaceutical dosage form containing phenylphrine
IL194277A0 (en)	2009-09-22	Solid oral dosage form containing an enhancer
EP2040731A4 (en)	2010-05-19	Solid oral dosage form containing an enhancer
PL2077729T3 (en)	2014-11-28	Probiotic oral dosage forms
IL193727A0 (en)	2009-05-04	Dosage forms for administering combinations of drugs
PL2457563T3 (en)	2017-09-29	Zero-order modified release solid dosage forms
IL188313A0 (en)	2008-04-13	Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate
IL206159A0 (en)	2010-12-30	Oral pharmaceutical dosage forms
IL182255A0 (en)	2007-09-20	Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
PL2399579T3 (en)	2013-12-31	Pharmaceutical dosage forms
IL173866A0 (en)	2006-07-05	Sustained release dosage forms of ziprasidone
ZA200706731B (en)	2008-09-25	Dosage form and method for sustained release of a substituted pyrazine compound
PL1906961T3 (en)	2016-07-29	Solid dosage formulations of fentanyl having improved buccal adsorption
ZA200610770B (en)	2008-08-27	Dosage form for delivery of multiple drug forms
IL177402A0 (en)	2006-12-10	Composition for oral administration of tamsulosin hydrochloride
IL179992A0 (en)	2007-05-15	Immediate release formulations of memantine oral dosage forms
ZA200804734B (en)	2009-11-25	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0616703D0 (en)	2006-10-04	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0612326D0 (en)	2006-08-02	Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0403808D0 (en)	2004-03-24	Films for use as dosage forms
SE0602280L (en)	2007-05-01	Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Legal Events

Date	Code	Title	Description
2006-11-22	AT	Applications terminated before publication under section 16(1)